Representing a large international pharmaceutical company in the Intellectual Property Court
2017-2018
Cancellation of the Rospatent’s decision to recognize the invention as patentable.
The lawyers of the dispute resolution and intellectual property practices successfully represented a large international pharmaceutical company in the Intellectual Property Court in a case on challenging a Eurasian patent for a group of inventions. The case was resolved in favor of the Principal. The firm's lawyers managed to prove the absence of novelty and inventive level in the main invention of the group. As a result, the court reversed the Rospatent’s decision of recognizing the invention as patentable.
Next project